2017 Buyer’s Guide

This buyer’s guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

Occlutech's PmVSD Occluder Obtains CE Mark Approval

 

April 11, 2017—Occlutech recently announced that it has obtained European CE Mark approval for its perimembranous ventricular septal defect (PmVSD) occluder. Occlutech's PmVSD occluder consists of a flexible nitinol wire mesh with shape-memory properties. The device is specifically designed and indicated for the minimally invasive closure of PmVSDs, which represent 70% to 80% of all VSDs, noted Occlutech.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.